p53-mutant IHC may be a pitfall in the differential diagnosis with OED, in which patterns of p53-mutant immunoexpression have been recently described, including diffuse overexpression in tumor cells, null expression and, rarely, cytoplasmic expression in tumor cells [22]. The gene discussed is TP53; the disease is neoplasm.